Billy Grey
Chair of Research: 2009
Billy Grey died of glioblastoma multiforme on July 13, 2001, just before his 13th birthday. His life was one of
remarkable strength, courage, and love. While receiving unsurpassed treatment from the dedicated teams at Duke University Medical Center and Dana-Farber Cancer Institute, Billy never lost his passion and spirit for life. Throughout his diagnosis and treatment, that included bi-weekly cross-state journeys for a clinical trial, he continued to attend school at Albany Academy where he excelled in both sports and academics.
The Billy Grey Chair of Research exists to find a cure because the Grey family knows that Billy would want his struggles to have a positive impact on others. Billy’s research award is strengthened by the spirit and character in which he lived his life and enriched the lives of those around him.
Eric C. Holland, MD, PhD
Memorial Sloan-Kettering Cancer Center, New York, New York
Investigating the role of DNA damage response in gliomagenesis and “cancerstem cell” resistance to irradiation
This is a gene study of chk2’s role as a tumor suppressor. Chk2 is a protein that inhibits cell division and growth. The study plans to identify novel characteristics of a protein involved in the repair of DNA damage, the control of tumor growth, and response of tumors to radiation therapy.
Tumor: High grade gliomas, Medulloblastoma
|